ANXA1 and disorder of glycogen metabolism: We performed IHC analysis to study the expression of ANXA1 in 14 controls (2 healthy liver donors and 12 GSD cases) and 43 GBC cases (16 early stage and 27 advanced stage GBC cases) and found ‘high’ expression levels in 72% of GBC cases.